Bleeding Risk Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer in Men on Baseline Anticoagulant or Antiplatelet Therapy

Bleeding Risk Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer in Men on Baseline Anticoagulant or Antiplatelet Therapy

PurposePatients on anticoagulant/antiplatelet medications are at a high risk of bleeding following external beam radiation therapy for localized prostate cancer. SBRT may reduce the bleeding risk by decreasing the volume of bladder/rectum receiving high doses. This retrospective study sought to eval...

Full description

Bibliographic Details
Main Authors: Abigail Pepin, Sarthak Shah, Monica Pernia, Siyuan Lei, Marilyn Ayoob, Malika Danner, Thomas Yung, Brian T. Collins, Simeng Suy, Nima Aghdam, Sean P. Collins
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
stereotactic body radiation therapy
anticoagulation
antiplatelet
bleeding risk
prostate cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.722852/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.722852/full

Similar Items